← Back to Search

Augmented Pulse Oximetry for Pulmonary Embolism

N/A
Waitlist Available
Led By A. S. Keller, MD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18 years of age or greater
Room air SpO2 (oxygen saturation) less than 92% and newly-diagnosed PE (or controls with no PE) based on CT angiogram result
Must not have
Oxygen saturation less than 85% with more than 4 L supplemental oxygen
Timeline
Screening 3 weeks
Treatment Varies
Follow Up oxygen saturation (spo2) will be recorded prior to using the spirometer, at 1 minute (during use of the spirometer), at 2 minutes (at the end of using the spirometer), and at 4 minutes.
Awards & highlights
No Placebo-Only Group

Summary

This trial is designed to see if a change in oxygen saturation during deep inspiration can be used to rule out pulmonary embolism.

Who is the study for?
This trial is for adults with a new diagnosis of pulmonary embolism (PE) who have an oxygen saturation level below 92% and can follow study procedures. It excludes those unable to use the incentive spirometer, non-English speakers, patients from Federal Medical Center in Rochester, Minnesota, or those with certain unstable vital signs.
What is being tested?
The study tests if 'augmented pulse oximetry' using deep breaths measured by an incentive spirometer can help rule out PE. It involves comparing oxygen levels before, during, and after deep breathing in 40 patients with PE and 80 without.
What are the potential side effects?
Since this trial uses non-invasive augmented pulse oximetry via an incentive spirometer for diagnosis rather than treatment, significant side effects are not anticipated.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
My oxygen levels are below 92% without extra oxygen, and I have a new pulmonary embolism diagnosis.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
My oxygen levels are below 85% even with more than 4L of extra oxygen.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~the single maximum value obtained prior to using the spirometer, at 1 minute (during use of the spirometer), at 2 minutes (at the end of using the spirometer), and at 4 minutes.
This trial's timeline: 3 weeks for screening, Varies for treatment, and the single maximum value obtained prior to using the spirometer, at 1 minute (during use of the spirometer), at 2 minutes (at the end of using the spirometer), and at 4 minutes. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in oxygen saturation using augmented pulse oximetry for patients with and without pulmonary embolism.
Secondary study objectives
Vital capacity (the maximal amount of air that can be inhaled, measured in milliliters) during augmented pulse oximetry.

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Control patientsExperimental Treatment2 Interventions
Augmented pulse oximetry using incentive spirometer. Emergency Department patients who do not have pulmonary embolism.
Group II: Proven pulmonary embolism.Active Control2 Interventions
Augmented pulse oximetry using incentive spirometer. Emergency Department patients with pulmonary embolism.

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,339 Previous Clinical Trials
3,060,645 Total Patients Enrolled
1 Trials studying Pulmonary Embolism
10,000 Patients Enrolled for Pulmonary Embolism
A. S. Keller, MDPrincipal InvestigatorMayo Clinic
1 Previous Clinical Trials
84 Total Patients Enrolled

Media Library

Control patients Clinical Trial Eligibility Overview. Trial Name: NCT01898637 — N/A
Pulmonary Embolism Research Study Groups: Proven pulmonary embolism., Control patients
Pulmonary Embolism Clinical Trial 2023: Control patients Highlights & Side Effects. Trial Name: NCT01898637 — N/A
Control patients 2023 Treatment Timeline for Medical Study. Trial Name: NCT01898637 — N/A
~0 spots leftby Dec 2024